UCH-L1, S100B, SBDP150, IL-6, and IL-1 receptor antagonist were significantly elevated at the early acute phase post-injury vs. baseline, whereas GFAP was elevated post-injury vs. baseline in concussed athletes with a loss of consciousness or amnesia; IL-1 receptor antagonist was correlated with recovery. The gene discussed is GFAP; the disease is amnesia.